| | | | | | | |
 | JOHNSON & JOHNSON | -0.45% | -2.15% | -7.94% | -4.93% | 7.06% | 427 102 |
| ELI LILLY AND COMPANY | -0.21% | -0.88% | -7.90% | 38.35% | 130.14% | 320 837 |
 | NOVO NORDISK A/S | 0.85% | -0.36% | 3.00% | 45.08% | 123.35% | 311 923 |
 | ROCHE HOLDING AG | 0.21% | -1.49% | -2.07% | -17.49% | -16.32% | 269 272 |
| MERCK & CO., INC. | 0.76% | -1.94% | -5.53% | 35.11% | 23.20% | 263 757 |
| ABBVIE INC. | -0.23% | -0.43% | -10.47% | 1.52% | 56.78% | 256 378 |
| PFIZER, INC. | -0.47% | 0.62% | -15.00% | -18.15% | 14.47% | 245 639 |
 | ASTRAZENECA PLC | 0.06% | -1.21% | -5.63% | 26.81% | 37.75% | 197 087 |
| NOVARTIS AG | 0.19% | -4.83% | -5.13% | -1.37% | -15.44% | 180 893 |
| BRISTOL-MYERS SQUIBB COMPANY | 0.03% | 2.76% | 3.61% | 12.63% | 12.53% | 165 430 |
| AMGEN INC. | -0.08% | -3.34% | -7.23% | 9.01% | 6.25% | 130 113 |
| GILEAD SCIENCES, INC. | -0.25% | 0.92% | 0.34% | 35.11% | 25.08% | 107 691 |
| GSK PLC | 1.68% | 3.40% | 3.34% | -27.45% | -30.10% | 70 859 |
 | BAYER AG | 1.31% | 2.27% | 21.99% | 11.04% | -24.06% | 61 378 |
 | DAIICHI SANKYO CO., LTD. | -0.42% | -4.38% | -4.24% | 76.19% | 49.56% | 59 046 |
| | | | | | | |
| | Durchschnitt | 0.20% | -0.74% | -2.59% | 14.76% | 26.68% | |
| | Gewichteter Durchschnitt nach Marktkapitalisierung | 0.09% | -1.00% | -4.69% | 13.06% | 36.72% | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Bericht
